Mission Bio Breaking News FDA Approves Keytruda-Herceptin Combination for HER2-Positive Gastric, Gastroesophageal Cancer Vivace Therapeutics Begins Phase I Trial of TEAD Inhibitor AstraZeneca, Alchemab Partner on Prostate Cancer Immunotherapy Research Veterans Affairs Funds $5M Effort to Expand Precision Lung Cancer Trials in Southeast US FDA Accepts IND for Clarity Pharmaceuticals' Prostate Cancer Radiopharmaceutical Vanguard Cancer Foundation Puts $2M Gift Toward Nagourney Cancer Institute's Metabolomics Research
